Literature DB >> 23149597

Bioluminescent bacterial imaging in vivo.

Chwanrow K Baban1, Michelle Cronin, Ali R Akin, Anne O'Brien, Xuefeng Gao, Sabin Tabirca, Kevin P Francis, Mark Tangney.   

Abstract

This video describes the use of whole body bioluminesce imaging (BLI) for the study of bacterial trafficking in live mice, with an emphasis on the use of bacteria in gene and cell therapy for cancer. Bacteria present an attractive class of vector for cancer therapy, possessing a natural ability to grow preferentially within tumors following systemic administration. Bacteria engineered to express the lux gene cassette permit BLI detection of the bacteria and concurrently tumor sites. The location and levels of bacteria within tumors over time can be readily examined, visualized in two or three dimensions. The method is applicable to a wide range of bacterial species and tumor xenograft types. This article describes the protocol for analysis of bioluminescent bacteria within subcutaneous tumor bearing mice. Visualization of commensal bacteria in the Gastrointestinal tract (GIT) by BLI is also described. This powerful, and cheap, real-time imaging strategy represents an ideal method for the study of bacteria in vivo in the context of cancer research, in particular gene therapy, and infectious disease. This video outlines the procedure for studying lux-tagged E. coli in live mice, demonstrating the spatial and temporal readout achievable utilizing BLI with the IVIS system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23149597      PMCID: PMC3578263          DOI: 10.3791/4318

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

Review 1.  PET imaging for gene & cell therapy.

Authors:  Sara A Collins; Kei Hiraoka; Akihito Inagaki; Noriyuki Kasahara; Mark Tangney
Journal:  Curr Gene Ther       Date:  2012-02-01       Impact factor: 4.391

2.  Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

Authors:  Michelle Cronin; David Morrissey; Simon Rajendran; Shereen M El Mashad; Douwe van Sinderen; Gerald C O'Sullivan; Mark Tangney
Journal:  Mol Ther       Date:  2010-04-13       Impact factor: 11.454

3.  Gene therapy for prostate cancer.

Authors:  Mark Tangney; Sarfraz Ahmad; Sara A Collins; Gerald C O'Sullivan
Journal:  Postgrad Med       Date:  2010-05       Impact factor: 3.840

Review 4.  Tumour targeting with systemically administered bacteria.

Authors:  David Morrissey; Gerald C O'Sullivan; Mark Tangney
Journal:  Curr Gene Ther       Date:  2010-02       Impact factor: 4.391

5.  Three-dimensional reconstruction of in vivo bioluminescent sources based on multispectral imaging.

Authors:  Chaincy Kuo; Olivier Coquoz; Tamara L Troy; Heng Xu; Brad W Rice
Journal:  J Biomed Opt       Date:  2007 Mar-Apr       Impact factor: 3.170

6.  In vivo bioluminescence imaging for the study of intestinal colonization by Escherichia coli in mice.

Authors:  M-L Foucault; L Thomas; S Goussard; B R Branchini; C Grillot-Courvalin
Journal:  Appl Environ Microbiol       Date:  2009-10-30       Impact factor: 4.792

7.  Tumor-targeting prodrug-activating bacteria for cancer therapy.

Authors:  C-M Cheng; Y-L Lu; K-H Chuang; W-C Hung; J Shiea; Y-C Su; C-H Kao; B-M Chen; S Roffler; T-L Cheng
Journal:  Cancer Gene Ther       Date:  2008-03-28       Impact factor: 5.987

Review 8.  Viral vectors in cancer immunotherapy: which vector for which strategy?

Authors:  Sara A Collins; Barbara-Ann Guinn; Patrick T Harrison; Martina F Scallan; Gerald C O'Sullivan; Mark Tangney
Journal:  Curr Gene Ther       Date:  2008-04       Impact factor: 4.391

9.  Establishment and characterization of conditions required for tumor colonization by intravenously delivered bacteria.

Authors:  Yong A Yu; Qian Zhang; Aladar A Szalay
Journal:  Biotechnol Bioeng       Date:  2008-06-15       Impact factor: 4.530

10.  A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy.

Authors:  Jan Peter van Pijkeren; David Morrissey; Ian R Monk; Michelle Cronin; Simon Rajendran; Gerald C O'Sullivan; Cormac G M Gahan; Mark Tangney
Journal:  Hum Gene Ther       Date:  2010-04       Impact factor: 5.695

View more
  8 in total

1.  Bacterial-mediated knockdown of tumor resistance to an oncolytic virus enhances therapy.

Authors:  Michelle Cronin; Fabrice Le Boeuf; Carola Murphy; Dominic G Roy; Theresa Falls; John C Bell; Mark Tangney
Journal:  Mol Ther       Date:  2014-02-26       Impact factor: 11.454

Review 2.  Options and Limitations in Clinical Investigation of Bacterial Biofilms.

Authors:  Maria Magana; Christina Sereti; Anastasios Ioannidis; Courtney A Mitchell; Anthony R Ball; Emmanouil Magiorkinis; Stylianos Chatzipanagiotou; Michael R Hamblin; Maria Hadjifrangiskou; George P Tegos
Journal:  Clin Microbiol Rev       Date:  2018-04-04       Impact factor: 26.132

3.  Validation of a Standard Luminescence Method for the Fast Determination of the Antimicrobial Activity of Nanoparticles in Escherichia coli.

Authors:  Gonçalo A Marcelo; Joana Galhano; Maria Paula Duarte; José Luis Capelo-Martínez; Carlos Lodeiro; Elisabete Oliveira
Journal:  Nanomaterials (Basel)       Date:  2022-06-23       Impact factor: 5.719

4.  Studying interactions of Staphylococcus aureus with neutrophils by flow cytometry and time lapse microscopy.

Authors:  Bas G J Surewaard; Jos A G van Strijp; Reindert Nijland
Journal:  J Vis Exp       Date:  2013-07-17       Impact factor: 1.355

5.  Imaging of tumor clones with differential liver colonization.

Authors:  Go Oshima; Sean C Wightman; Abhineet Uppal; Melinda E Stack; Sean P Pitroda; Jonathan J Oskvarek; Xiaona Huang; Mitchell C Posner; Samuel Hellman; Ralph R Weichselbaum; Nikolai N Khodarev
Journal:  Sci Rep       Date:  2015-06-22       Impact factor: 4.379

6.  Tn5/7-lux: a versatile tool for the identification and capture of promoters in gram-negative bacteria.

Authors:  Steven T Bruckbauer; Brian H Kvitko; RoxAnn R Karkhoff-Schweizer; Herbert P Schweizer
Journal:  BMC Microbiol       Date:  2015-02-04       Impact factor: 3.605

7.  Intratumoural production of TNFα by bacteria mediates cancer therapy.

Authors:  Carola Murphy; Elizabeth Rettedal; Panos Lehouritis; Ciarán Devoy; Mark Tangney
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

8.  Efficient protection of microorganisms for delivery to the intestinal tract by cellulose sulphate encapsulation.

Authors:  Walter H Gunzburg; Myo Myint Aung; Pauline Toa; Shirelle Ng; Eliot Read; Wee Jin Tan; Eva Maria Brandtner; John Dangerfield; Brian Salmons
Journal:  Microb Cell Fact       Date:  2020-11-26       Impact factor: 5.328

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.